Provided by Tiger Trade Technology Pte. Ltd.

Stoke Therapeutics, Inc.

25.62
-0.3900-1.50%
Post-market: 25.620.00000.00%19:30 EDT
Volume:848.62K
Turnover:21.88M
Market Cap:1.65B
PE:-7.69
High:26.46
Open:26.46
Low:25.45
Close:26.01
52wk High:40.22
52wk Low:20.32
Shares:64.53M
Float Shares:49.01M
Volume Ratio:0.61
T/O Rate:1.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3325
EPS(LYR):-0.1163
ROE:-61.10%
ROA:-35.87%
PB:4.78
PE(LYR):-220.36

Loading ...

Stoke Therapeutics shareholders elect three Class I directors at annual meeting

Reuters
·
Jun 05

Stoke Therapeutics CMO Barry Ticho sells 1,795 common shares for $54,886.1

Reuters
·
Jun 04

Stoke Therapeutics to present at Jefferies Global Healthcare Conference

Reuters
·
May 29

Stoke Therapeutics grants new hires options for 106,200 shares at $30.08

Reuters
·
May 19

Stoke Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Stoke Therapeutics Q1 FY26 net loss widens to $50 million; revenue drops to $6.2 million

Reuters
·
May 08

Stoke Therapeutics Q1 EPS USD -0.79

THOMSON REUTERS
·
May 08

Stoke Therapeutics CMO Barry Ticho disposes of 2,243 shares for $73,528.97

Reuters
·
May 06

Stoke Therapeutics schedules webcast, conference call for first-quarter business and financial updates

Reuters
·
May 01

Stoke Therapeutics announces annual shareholder meeting via webcast

Reuters
·
Apr 23

BRIEF-Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Apr 17

Stoke Therapeutics grants 129,565 inducement stock options to new employees at $35.54/share

Reuters
·
Apr 17

Did Stoke's New R&D Chair Appointment Just Reshape Stoke Therapeutics' (STOK) Antisense Strategy Priorities?

Simply Wall St.
·
Apr 16

Stoke Therapeutics CEO to present at Needham Virtual Healthcare Conference

Reuters
·
Apr 09

Stoke Therapeutics appoints Clare Kahn to board of directors

Reuters
·
Apr 08

Stoke Therapeutics Appoints Clare Kahn, Ph.d., to Its Board of Directors

THOMSON REUTERS
·
Apr 08